Stocktoria
Viridian Therapeutics, Inc.DE VRDN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-06-18
Viridian Therapeutics, Inc.DE institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,773,622 | $62.1M | 4.69% |
| CITADEL ADVISORS LLC | 2,382,934 | $46.6M | 2.34% |
| D. E. Shaw & Co., Inc. | 1,262,540 | $24.7M | 1.24% |
| Point72 Asset Management, L.P. | 322,836 | $6.3M | 0.32% |
| RENAISSANCE TECHNOLOGIES LLC | 203,100 | $4.0M | 0.2% |
| MILLENNIUM MANAGEMENT LLC | 140,595 | $2.8M | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 35,114 | $686,830 | 0.03% |
| AQR CAPITAL MANAGEMENT LLC | 20,208 | $395,269 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.